The possibility that anesthesia during cancer surgery may affect cancer recurrence, metastasis, and patient prognosis has become one of the most important topic of interest in cancer treatment. For example, the volatile anesthetic isoflurane was reported in several studies to induce hypoxia-inducible factors, and thereby enhance malignant phenotypes in vitro. Indeed, these transcription factors are considered critical regulators of cancer-related hallmarks, including "sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, replicative immortality, angiogenesis, invasion, and metastasis." We have now investigated the impact of isoflurane on the growth and migration of derivatives of the renal cell line RCC4. We confirmed that hypoxia-inducible factors do promote tumor growth and migration, but found that isoflurane does not affect cancerous phenotypes due to such factors.
Introduction
The hypothesis that anesthesia during cancer surgery may affect tumor recurrence, metastasis, and patient prognosis 1,2 is gaining increasing importance at present 3 .
Accordingly, there is a growing body of in vitro, in vivo, retrospective, and translational studies on the effect of anesthetics on perioperative immunity and cancer metastatic potential. For example, isoflurane was reported in several studies to induce hypoxia-inducible transcription factors (HIFs), and thereby enhance malignant phenotypes in vitro [4] [5] [6] . HIF-1 was originally cloned as a driver of erythropoietin expression [7] [8] [9] [10] , but was linked shortly thereafter to tumor grade in various cancers 11 .
Indeed, HIFs are now well-known as critical regulators of cancer hallmarks, including "sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, replicative immortality, angiogenesis, invasion, and metastasis" 12, 13 . Moreover, tumor suppressors such as TP53 and PTEN also regulate HIFs. Another striking example of the physiological significance of HIFs is von Hippel-Lindau (VHL) disease, a hereditary cancer syndrome that predisposes to highly angiogenic tumors, in which the constitutive overexpression of vascular endothelial growth factor and glucose transporter 1 can be corrected by functional VHL protein, a tumor suppressor that targets HIFs for degradation. In this study, we investigated the impact of the volatile anesthetic isoflurane on growth and migration of derivatives of the renal cell line RCC4
that express (RCC-VHL) or do not express (RCC4-EV) VHL 14 . We demonstrate that
HIFs significantly influence growth and migration, but isoflurane does not affect HIF-dependent phenotypes.
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Results

HIF-1 and HIF-2 expression and activity in RCC4-EV and RCC4-VHL cells
HIF-1α and HIF-2α protein were detected at 20 % O 2 in RCC4-EV cells, but not in RCC4-VHL cells (Fig. 1a) . Similar levels of expression were observed in the former at 1 % O 2 (Fig. 1a) . In addition, expression in RCC4-EV cells was insensitive to 2 % isoflurane at 20 % O 2 (Fig. 1b) . In contrast, HIF-1α and HIF-2α were barely detectable in RCC4-VHL cells even after exposure to 20 % O 2 for 8 h with or without 2 % isoflurane (Fig. 1b) . However, HIF-1α and HIF-2α were induced in RCC4-VHL cells at 1 % O 2 ( Fig. 1a ), but were suppressed by isoflurane (Fig. 1c) . To investigate possible protocol-dependent effects, HIF-1α was also quantified in RCC4-EV and RCC4-VHL However, expression in RCC4-VHL cells at 1 % O 2 was suppressed by isoflurane.
Interestingly, HIF1A and EPAS1 (HIF-2α) mRNAs were less abundant in RCC4-EV cells, but were insensitive to isoflurane (Figs. 2c and d).
Effect of isoflurane on cell proliferation
-5-Cell proliferation, as assessed by MTS assay, was higher in RCC4-EV cells than in RCC4-VHL cells, but was insensitive to isoflurane (Fig. 3a) . Similarly, cellular ATP was more abundant in the former than in the latter, and was also insensitive to isoflurane (Fig. 3b) .
Effect of isoflurane on cell migration
RCC4-EV cells migrated significantly faster than RCC4-VHL cells over 12 h (Fig. 4a) , although exposure to isoflurane for 2 h significantly suppressed migration in both cells (Fig. 4b) .
Effect of isoflurane on glucose metabolism
In comparison to normal cells, cancer cells exhibit the Warburg effect, and thus preferentially metabolize glucose by glycolysis, producing lactate as an end product, despite availability of oxygen. Using an Extracellular Flux Analyzer™, the mitochondrial oxygen consumption rate was found to be lower in RCC4-EV cells in comparison to RCC4-VHL cells (Fig. 5a ), but was insensitive to isoflurane (Fig. 5b ).
On the other hand, extracellular acidification rate was higher in RCC4-EV cells relative to RCC4-VHL cells (Fig. 5c ), but was also insensitive to isoflurane (Fig. 5d ). Key parameters that determine the mitochondrial oxygen consumption rate, including basal oxygen consumption rate, maximum respiration, proton leak, and nonmitochondrial respiration, were also calculated from Cell Mito Stress Test™ data (Fig. 6 ). These parameters were significantly different between RCC4-EV and RCC4-VHL cells, but were insensitive to isoflurane.
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Effect of isoflurane on global gene expression
Clustering of RNA sequencing data (Supplementary Information Table1) indicated that transcriptomic bias due to isoflurane was smaller than transcriptomic variations due to VHL expression (Fig. 7a) (Fig. 7d ) regardless of isoflurane exposure (Fig. 7e ).
Finally, only 42 genes annoted to cancer hallmark gene ontologies were sensitive to isoflurane, although the effects were negligible (Fig. 8) . Indeed, only CITED1 was strongly responsive to isoflurane.
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Discussion
Collectively, the data suggest that clinically relevant doses of isoflurane suppress cell mobility, HIF-dependent intracellular signaling, and expression of genes associated with cancer hallmarks and phenotypes. We also confirmed that HIFs sustain cancer-associated gene expression, metabolism, cell proliferation, and cell motility.
The hallmarks of cancer were originally proposed by Hanahan and Weinberg in 2000 12 , and included sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, replicative immortality, angiogenesis, invasion, and metastasis.
Subsequent conceptual progress has added another two emerging hallmarks, namely reprogramming of energy metabolism and evasion of immune destruction In summary, we demonstrated that isoflurane does not affect HIF activity in renal carcinoma cells, nor the expression of genes associated with cancer hallmarks.
However, we confirmed that HIFs help maintain cancerous phenotypes.
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Materials and methods
Cell culture and reagents
Renal cell carcinoma cell lines stably transfected with pcDNA3-VHL (RCC4-VHL) or empty pcDNA3 (RCC4-EV) were kindly provided by Dr. Hiroshi Harada (Kyoto University) 19 . These cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10 % fetal bovine serum, 100 U/mL penicillin, and 0.1 mg/mL (Table 1) .
Hypoxic and isoflurane treatment
Cells were maintained in an airtight chamber or workstation (AS-600P; AsOne, Osaka, .
Immunoblotting
Whole-cell lysates were prepared by incubating cells for 30 min in cold radioimmune 
Semi-quantitative real-time reverse transcriptase-polymerase chain reaction analysis (qRT-PCR)
Total RNA was extracted from cells using RNeasy™ Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. First-strand synthesis and RT-PCR were performed using QuantiTect™ Reverse Transcription Kit (Qiagen) and Rotor-Gene™ SYBR Green PCR Kit (Qiagen), following the manufacturer's protocol.
Targets were amplified and quantified in Rotor-Gene Q™ (Qiagen), and change in expression of each target mRNA was calculated relative to β -actin. SLC2A1 was quantified with the QuantiTect Primer Assay QT00068957, while VEGFA was quantified with forward primer AGCCTTGCCTTGCTGCTCT and reverse primer -11-TCCTTCTGCCATGGGTGC. HIF1A was quantified using the forward and reverse primers ACACACAGAAATGGCCTTGTGA and CCTGTGCAGTGCAATACCTTC, while EPAS1 was quantified with the forward and reverse primers ATGGGACTTACACAGGTGGAG and GCTCTGTGGACATGTCTTTGC. 
Assessment of cell growth
Cell migration assay
Cell migration was analyzed using Oris™ Cell Migration Assay (Platypus Thechnologies, Madison, WI). Cells (2 × 10 4 ) were seeded in wells plugged with stoppers to restrict seeding to outer areas only. Cells were then exposed for 8 h to 21 % oxygen and 5 % carbon dioxide balanced with nitrogen with or without 2 % isoflurane.
Stoppers were then removed to expose unseeded sites, into which cells could migrate during subsequent incubation at 37 °C in 5 % CO 2 and 95 % air for indicated times. Cell migration was imaged on a BZ-9000 Fluorescence Microscope (KEYENCE, Itasca, IL), and colonized areas were quantified in pixels in ImageJ 1.51 (National Institutes of Health), corrected for total unseeded area, and expressed as percentage of colonized areas in reference wells.
RNA sequencing
Total RNA was extracted from cells using RNeasy Mini Kit (Qiagen) 19, 25 , and processed using TruSeq Stranded mRNA Sample Prep Kit (Illumina, San FASTQ files were evaluated as described previously 19, 25 . In brief, gene lists for Metascape analysis were generated from the Cuffdiff output file of significantly differentially expressed genes (p < 0.05; Table S1 ). Gene ontology annotations were extracted in Ensembl Biomart 27 , and sorted by the common logarithms of ([FPKM of 
Statistical analysis
Experiments were repeated at least twice with triplicates of each sample. Data are mean ± SD. Groups were compared in Prism 7™ (GraphPad Software, Inc. La Jolla, CA) by one-way analysis of variance or Dunnett's test for multiple comparisons. p values < 0.05 indicated statistical significance.
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